Avent ND, Martin PG. Kell typing by allele-specific PCR(ASP). Br J Haematol 1996;93:728–30.10.1046/j.1365-2141.1996.d01-1695.xSearch in Google Scholar
Balachandran V, Nair PM, Prasad K. Change in blood group phenotype. J Indian Med Assoc 1996;94:151–3.Search in Google Scholar
Beckers EAM, Faas BHW, Ligthart P, et al. Characterization of the hybrid RHD gene leading to
the partial D category IIIc phenotype. Transfusion 1996;36:567–74.10.1046/j.1537-2995.1996.36696269518.xSearch in Google Scholar
Faas BHW, Beckers EAM, Simsek S, et al. Involvement of Ser 103 of the Rh polypeptides in G epitope formation. Transfusion 1996;36:506–11.10.1046/j.1537-2995.1996.36696269508.xSearch in Google Scholar
Hausman E, Dzik W, Blanchard D. The red cell chemokine receptor is distinct from the Fy6 epitope. Transfusion 1996;36:421–5.10.1046/j.1537-2995.1996.36596282585.xSearch in Google Scholar
Hessner MJ, McFarland JG, Endean DJ. Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers. Transfusion 1996;36: 495–9.10.1046/j.1537-2995.1996.36696269506.xSearch in Google Scholar
Huang CH, Reid ME, Xie SS, Blumenfeld OO. Human red blood cells Wright antigens: a genetic and evolutionary perspective on glycophorin A- band 3 interaction. Blood 1996;87:3942–7.10.1182/blood.V87.9.3942.bloodjournal8793942Search in Google Scholar
Issitt PD, Telen MJ. Introduction of the term “partial D” (letter). Transfusion 1996;36:761.Search in Google Scholar
Judd WJ, Annesley TM. The acquired-B phenomenon. Transfus Med Rev 1996;10:111–7.10.1016/S0887-7963(96)80087-3Search in Google Scholar
Komatsu F, Kajiwara M. Transient depression of LWa antigen with coincident production of anti-LWa repeated in relapses of malignant lymphoma. Transfus Med 1996;6:139–43.10.1046/j.1365-3148.1996.d01-63.x8809962Search in Google Scholar
Lee S, Wu X, Son S, et al. Point mutations characterize KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles. Transfusion 1996;36: 490–4.10.1046/j.1537-2995.1996.36696269505.x8669078Search in Google Scholar
Lindstrom K, Jovall PA, Ghardashkani S, Samuelsson BE, Breimer ME. Blood group glycosphingolipid expression in kidney of an individual with the rare blood group A1 Le(a–b+) p phenotype: absence of blood group structures based on the globoseries. Glycoconj J 1996;13:307–13.10.1007/BF007315058737255Search in Google Scholar
Mak KH, Lubenko A, Greenwell P, Voak D, Yan KF, Poole J. Serologic characteristics of H-deficient phenotypes among Chinese in Hong Kong. Transfusion 1996;36:994–9.10.1046/j.1537-2995.1996.36111297091745.x8937411Search in Google Scholar
Mudad R, Rao N, Issitt PD, Roy RB, Combs MR, Telen MJ. JMH variants: serologic, clinical, and biochemical analyses in two cases. Transfusion 1995;35:925–30.10.1046/j.1537-2995.1995.351196110897.x8604490Search in Google Scholar
Reid ME, Chandrosekaran V, Sausais L, Pierre J, Bullock R. Disappearance of Cromer antibodies to Cromer blood group antigens during mid pregnancy. Vox Sang 1996;71:48–50.10.1046/j.1423-0410.1996.7110048.x8837357Search in Google Scholar
Reid ME, Storry JR, Ralph H, Blumenfeld OO, Huang C-H. Expression and quantitative variation of theSearch in Google Scholar
